🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Fate Therapeutics, Inc.
Market Cap: Medium
Employees: Low
programmed cellular immunotherapies
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its development programs include various NK- and T-cell immuno-oncology therapies targeting different cancers.
Website
Vision/Values | About | Management | Directors | About | Contact
Symbol: FATE
Recent Price: $1.62
Industry: Biotechnology
CEO: Mr. J. Scott Wolchko
Sector: Healthcare
Employees: 181
Address: 12278 Scripps Summit Drive, San Diego, CA 92131
Phone: 858 875 1800
Leadership
- William Rastetter, Ph.D., Chairman
- John Mendlein, Ph.D., J.D., Vice Chairman
- Dr. Shefali Agarwal, Board Member
- Timothy P. Coughlin, Board Member
- Robert S. Epstein, M.D., Board Member
- Karin Jooss, Ph.D., Board Member
- Michael Lee, Board Member
- Neely Mozaffarian, M.D., Ph.D., FACR, Board Member
- Yuan Xu, Ph.D., Board Member
- Scott Wolchko, President & CEO
Last updated: 2024-12-31